Considerations for the use of imaging tools for phase II treatment trials in oncology

Lalitha K Shankar1, Annick Van den Abbeele, Jeff Yap

  • 1Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA. shankarl@mail.nih.gov